Nanobodies represent the variable binding domain of camelid heavy-chain antibodies and are employed in a rapidly growing range of applications in biotechnology and biomedicine. Their success is based on unique properties including their reported ability to reversibly refold after heat-induced denaturation. This view, however, is contrasted by studies which involve irreversibly aggregating nanobodies, asking for a quantitative analysis that clearly defines nanobody thermoresistance and reveals the determinants of unfolding reversibility and aggregation propensity. By characterizing nearly 70 nanobodies, we show that irreversible aggregation does occur upon heat denaturation for the large majority of binders, potentially affecting application-relevant parameters like stability and immunogenicity. However, by deriving aggregation propensities from apparent melting temperatures, we show that an optional disulfide bond suppresses nanobody aggregation. This effect is further enhanced by increasing the length of a complementarity determining loop which, although expected to destabilize, contributes to nanobody stability. The effect of such variations depends on environmental conditions, however. Nanobodies with two disulfide bonds, for example, are prone to lose their functionality in the cytosol. Our study suggests strategies to engineer nanobodies that exhibit optimal performance parameters and gives insights into general mechanisms which evolved to prevent protein aggregation.
Results
Irreversible processes are a substantial part of heat-induced nanobody denaturation. The nanobody scaffold has been reported repeatedly to reversibly refold after heat-denaturation, apparently devoid of aggregation, a view that is contrasted by several examples of aggregating nanobody binders. To properly define the thermoresistance of the nanobody fold in general and to reveal the molecular basis of both nanobody aggregation and reversible refolding, we characterized 68 affinity-matured, dromedary-and llama-derived nanobodies SCientiFiC REPORTS | (2018) 8:7934 | DOI:10.1038/s41598-018-26338-z employing differential scanning fluorimetry (DSF) and parallel turbidity assays. Relevant parameters were obtained as illustrated in Fig. 1B . Performing measurements at nanobody concentrations of 13.1 and 32.7 µM (corresponding to around 0.5 and 0.2 mg/ml) yielded a multidimensional data set on nanobody thermoresistance for a heating rate of 0.5 °C/min. First, we determined the fraction of aggregation-free nanobodies by means of turbidity assays. To ease interpretation, turbidity signals were integrated over a temperature range of 7 °C above the respective onset temperature of aggregation (T s ) ( Fig. 2A ; for raw traces see Supplementary Figure 1 ). At 32.7 µM, only 22.1% of the investigated binders were devoid of significant aggregation during the heating phase to 95 °C. At 13.1 µM, this fraction increased to 58.8%, indicating a strong concentration dependence of turbidity signals. When including the data of the cooling-phase ( Supplementary Figure 2) , the fractions of zero turbidity dropped to merely 2.0% at 32.7 µM and 15.6% at 13.1 µM, suggesting the presence of at least some aggregation for a substantial percentage of nanobodies.
Second, we measured the fraction of reversibly refolding nanobodies by comparing fluorescence ratio values prior and after a complete heating and cooling cycle ( Fig. 2C ). After one cycle at 32.7 µM, only 1.5% of the binders fully recovered the initial fluorescence level, increasing to 4.4% at 13.1 µM. While these numbers might be biased due to unequilibrated refolding reactions for some binders 39 , they are in basic agreement with the aggregation data obtained in the turbidity assays ( Fig. 2A and B ). Furthermore, melting curves for two representative nanobodies were monitored using CD spectroscopy, showing that merely 1% and 43% of the folding amplitude were recovered after a full temperature cycle for nanobodies NbD3 and NbD1, respectively (see Supplementary  Figure 3 and compare their turbidity integrals in Fig. 2A ). These data clearly confirmed that for a large fraction of nanobodies, irreversible processes take place upon heat-induced denaturation.
Aggregation is the major source of irreversibility of heat-induced nanobody denaturation. To attribute these observations to the occurrence of protein aggregates, the kinetics of monomer loss was measured for six nanobodies that were picked from across the entire range of turbidity integrals in Fig. 2A . They revealed a broad range of aggregation rates covering several orders of magnitude ( Fig. 3A) . Also, the presence of a threshold concentration was shown, which was required for aggregation in case of NbSH2D2A_1 (for first order rate constants and final amplitudes see Supplementary Table 1) . Notably, the observed aggregation rates roughly reflected the corresponding turbidity integrals (see labels in Fig. 2A for comparison). A structural characterization using electron microscopy ( Fig. 3D -G) showed that aggregated nanobodies form round-shaped particles with a diameter of around 20 nm which further crosslink to higher order aggregates upon prolonged heating, a process which we confirmed to be irreversible by showing that incubation at room temperature for 24 h did not reverse aggregation ( Supplementary Figure 4) .
For each nanobody, we determined the temperature regime of the respective aggregation onset, revealing that the majority of binders aggregated within the unfolding transition or at higher temperatures ( Fig. 3B ; see Supplementary Figure 5 for an illustration of aggregation regimes). The fact that aggregation was not detected below the onset temperature of unfolding (T on ) indicated that aggregation requires nanobody unfolding. This is documented by (i) the comparison of T s and T on values ( Fig. 3C ), (ii) the detection of highly homogeneous and monomeric nanobodies using analytical ultracentrifugation (Supplementary Figure 6 ), and (iii) the absence of aggregates prior to heating (Fig. 3D ). The last was confirmed by the exclusive detection of monodisperse protein peaks in size exclusion chromatography under such conditions (data not shown). Furthermore, apparent 1 st order SCientiFiC REPORTS | (2018) 8:7934 | DOI:10.1038/s41598-018-26338-z aggregation kinetics was obtained ( Fig. 3A) , a phenomenon commonly observed if protein unfolding represents the rate-limiting step in the aggregation reaction 40 . Small nanobody fractions aggregated at temperatures above the completed unfolding transition or during the cooling phase.
In summary, these results underlined the remarkable solubility of native nanobodies but confirmed that irreversible aggregation is a serious phenomenon in heat-induced nanobody denaturation for the majority of binders.
The ΔTm shift as a numeric description of nanobody aggregation propensity. Particularly in a therapeutic context, non-native protein aggregation poses a serious risk, e.g. triggering immune responses in patients 41, 42 . Therefore, it is of considerable interest to study its determinants for avoiding risk factors or potentially restoring nanobody folding reversibility through protein engineering. However, a comparison of aggregation propensities among a set of binders as diverse as ours remains challenging 43, 44 . Turbidity signals are qualitative due to their dependence on aggregate size and shape 44 . Therefore, we approached a quantification of nanobody aggregation propensities by means of apparent T m values, which are solely a function of kinetic parameters. Following Le Chatelier's principle 45 , aggregation of unfolded nanobodies will cause the folding equilibrium to shift towards the unfolded state, reflected in apparently decreased T m values in thermal scans 46 as demonstrated ( Fig. 1C ). Aggregation rates are strongly concentration-dependent, allowing a modulation of this reaction and thus an investigation of its effect on T m . Two factors influence the shift of apparent T m values: the intrinsic aggregation rate and the kinetic stability of a nanobody 33, 34, 47 . The higher the latter the more inert is the folding equilibrium towards aggregation, resulting in smaller shifts.
By relating apparent T m values at two concentrations, a simple measure of this effect is obtained, which we called ΔT m shift. To characterize it, apparent T m values of four nanobodies were determined as a function of concentration (Fig. 4A ). The observed curve shapes ranged from hyperbolic to nearly linear for NbD3 and NbOSTP_2, respectively, indicating various susceptibilities of the folding equilibrium or different aggregation rates. The concentrations chosen in the data set appeared to be ideal to cover different shapes, which are reflected in the resulting ΔT m values. Furthermore, the results indicated that the concentration range chosen to The second disulfide bond and its role in nanobody aggregation. Using the ΔT m shift, we investigated the role of an optional second disulfide bond, a characteristic structural feature of some nanobodies, and its effect on aggregation. For this, the analysis was limited to dromedary-derived nanobodies (n = 50), as a second disulfide bond was not observed in any of the llama-derived binders of our set. Second, a quantification of ΔT m is meaningful only for those nanobodies, which aggregate within the temperature range of their unfolding transition. Only in this case, aggregation can affect the folding equilibrium. Nanobodies that aggregated outside of this temperature range were excluded.
Interestingly, a comparison of ΔT m values indicated a significantly reduced aggregation propensity in presence of a second disulfide bond in dromedary-derived nanobodies ( Fig. 5A , p = 0.0031). The binders chosen for measuring the kinetics of aggregation and the concentration dependence of ΔT m clearly supported this effect: nanobodies with two disulfide bonds had the slowest aggregation rates (orange traces in Fig. 3A ) and the least concentration dependence of ΔT m (orange trace in Fig. 4A ). Although a quantitative treatment of turbidity integrals needs to be handled with care, they were compared between both nanobody groups (including all dromedary nanobodies with a significant scattering onset T s ). While not significant at 13.1 µM, turbidity integrals were clearly lower for nanobodies with two disulfide bonds at 32.7 µM (p = 0.006, Supplementary Figure 7) , supporting the significance of the above finding based on ΔT m analysis. We concluded that besides its well established effect on conformational stability of nanobodies ( Supplementary Figure 8 ) and its contribution to binding affinity 48 , a third function of the second disulfide bond is to reduce nanobody aggregation, which could be due to an increase in kinetic stability, a reduction of the intrinsic aggregation rate, or due to a mixture of both effects. Nanobody thermoresistance is a function of CDR3 length. Notably, the second disulfide bond in nanobodies is commonly believed to rigidify and stabilize CDR3 loops which are particularly long 48, 49 . If conformational stability is considered, long flexible loops are expected to be destabilizing 48, [50] [51] [52] . However, their role in protein aggregation is more diverse: dynamic regions were shown to foster both aggregation 29, 31 and protein solubilization 32 . Therefore, it was interesting to ask if CDR3 loop length was somehow correlated with nanobody thermostability and aggregation behavior in presence and absence of a second disulfide bond. Surprisingly, a moderately positive correlation rather than the expected negative correlation of CDR3 length and nanobody thermostability was found both for nanobodies with one and two disulfide bonds (Fig. 5B) . Interestingly, the slight trend to higher stability with increasing CDR3 length was more significant in nanobodies with only one rather than two disulfide bonds. Considering the numerous factors which govern protein stability 53, 54 , it is not surprising that such a positive trend remains moderate. The result strongly contrasted the expected destabilization caused by a long and flexible CDR3-loop, if it is not stabilized by an additional disulfide bond 48, [50] [51] [52] .
Similarly, the relationship of CDR3 loop-length and nanobody aggregation propensity was investigated using ΔT m shifts. Strikingly, while no correlation in nanobodies devoid of a second disulfide bond was detectable Fig. 5C ), suggesting that nanobody aggregation can be effectively reduced by a particularly long CDR3 loop, which is additionally stabilized by a second disulfide bond.
Reducing conditions challenge nanobody thermostability and their application as intrabodies.
The multifunctional role of the second disulfide bond -fostering conformational stability of nanobodies and contributing to binding affinity 48 as well as reducing aggregation -might prove problematic for applications under reducing conditions, such as expressing nanobodies in the cellular cytoplasm for microscopy or functional studies 12 . To address this, nanobody stability was investigated by DSF measurements in presence and absence of 25 mM of the mild reducing agent tris(2-carboxyethyl)phosphine (TCEP). While the expected destabilization did not lower the T m below a critical temperature of 37 °C in most cases ( Supplementary Figure 9 ), Fig. 5D indicates a 50% chance that the folding equilibrium of a nanobody with two disulfide bonds is significantly shifted towards the unfolded state at physiological conditions. This result can serve as a guideline for nanobody selections and could explain observations of activity loss for a significant number of nanobodies upon cytoplasmic expression 55 .
Discussion
Nanobodies represent an antibody-derived binder class with extraordinary potential and unique biophysical properties. Several examples of reversibly refolding nanobodies shaped this view, while nanobody aggregation and chemical modifications upon heat-denaturation were observed as well. To clarify the significance of nanobody aggregation besides reversible refolding upon heat-denaturation, we comprehensively characterized around 70 nanobodies in DSF and turbidity measurements. Our analysis defines a quantitative model of nanobody thermoresistance in which irreversible denaturation occurs to some degree for the majority of binders and is mainly caused by aggregation. Reversibly refolding nanobodies appear to represent the exception and not the rule. Chemical modifications were suggested as the dominant cause of nanobody inactivation, but are likely to play a minor or no role in our study, as they require prolonged incubation times at high temperature 20 . Despite our results, it needs to be stated clearly that, compared to conventional antibodies 56 , the general thermoresistance of nanobodies remains to be exceptional. Although using harsh conditions, a slow heating rate and high protein concentrations, a remarkable 60% of turbidity-free binders were observed at 95 °C and 13.1 µM. Furthermore, nanobody aggregation required protein unfolding, underlining the high solubility of native nanobodies. Finally, the small percentage of nanobodies that exhibited no aggregation at all and were fully reversible (Fig. 2) might be a too pessimistic result, as it was possibly influenced also by a slow refolding kinetics 39 . Nevertheless, using turbidity and centrifugation assays as well as electron microscopy, it was clearly demonstrated that aggregation plays a significant role in heat-induced nanobody denaturation, which should be considered for future applications, in particular toward therapeutic ones.
The knowledge about the extent of heat-induced aggregation further provides an opportunity of engineering nanobody stability 23 and raises fundamental questions about its determinants. We employed the ΔT m shift to identify structural features that foster nanobody reversibility. The ΔT m shift is a parameter that is particularly powerful for high-throughput stability measurements: it reflects two fundamental aspects of protein aggregation (kinetic stability and intrinsic aggregation rate), is independent of aggregate size or shape, and integrates the aggregation behavior of a protein over a large concentration range. Its application is limited to proteins, however, which aggregate within the unfolding transition. Furthermore, the concentration range chosen to calculate the ΔT m shift affects its amplitude differently, underestimating strongly aggregating nanobodies (e. g., NbD3 in Fig. 4A ). However, the effect of stabilizing features, such as disulfide bonds or CDR3 length, are expected to be even more pronounced when expanding the concentration range towards lower concentrations, illustrating the potential of a comparison of ΔT m shifts in high-throughput stability measurements. Finally, the fluorescence ratio approach used for the determination of protein melting temperatures in our study (350 nm/330 nm) was recently shown to lead to artefacts in special cases 57, 58 . This usually small but possible bias is dependent on the particular shape of fluorescence spectra prior and after protein unfolding and can shift the apparently measured T m value of a protein. However, the same fluorescence spectra measured at two concentrations should differ merely in amplitude but not in shape. Therefore, the ΔT m shift is expected to be entirely independent of these effects, further illustrating its robustness. In contrast, the general T m measurements in our study can in principle contain this bias. However, due to the large number of involved binders the conclusions obtained from our statistical analyses are not expected to be substantially affected.
Several principles of nanobody thermoresistance were revealed by this analysis. An additional disulfide bond in dromedary-derived nanobodies reduced nanobody aggregation in thermal scans. Two mechanisms can account for this phenomenon: first, the second disulfide bond could increase the kinetic stability, an ability attributed to disulfide bonds in previous studies [59] [60] [61] [62] , resulting in a folding equilibrium with reduced susceptibility to aggregation; second, disulfide bonds were proposed to protect native proteins from dysfunctional association 63, 64 suggesting a more direct interference of the additional bond with the aggregation reaction. In both mechanistic cases, it seems highly plausible that the former dimerization interface of nanobodies plays a central role for reversibility. Protein interfaces were proposed to have an increased aggregation propensity 63 . Accordingly, a long CDR3 loop, which is additionally stabilized by an extra disulfide bond, should effectively shield the aggregation-prone interface, as observed experimentally (Fig. 5C ). Furthermore, our results show (Fig. 5B ) that the expected destabilizing effect of a long loop 48,50-52 is more than compensated in nanobodies, most probably by shielding the dimerization site, thereby contributing to conformational stability. Considering these observations, it is tempting to speculate that besides an increase in sequence variability and an enlarged surface necessary for antigen binding 49 , stability and solubility were an evolutionary driving force for the development of long CDR3 loops in nanobodies.
The foregoing conclusions are based on nanobodies, which aggregated within the unfolding transition, that is about two thirds (64.6%) of all binders. Our analyses could not answer the question, if partly folded intermediates are involved within this temperature regime. Nevertheless, our observations challenge the common view of nanobodies as two-state folders 19 . In contrast, an aggregation reaction, which is independent of intermediates, seems plausible for the residual one-third fraction of nanobodies, aggregating within higher temperature regimes that are dominated by the unfolded state. Therefore, three common strategies to obtain fully reversible nanobodies are suggested: (i) favoring long CDR3 loops which are stabilized by a disulfide bond; (ii) stabilizing long CDR3 loops by other, non-covalent interactions; and (iii) solubilizing the unfolded state, for example by the introduction of repulsive charges 23, 25 . Importantly, the situation changes for two scenarios: First, in applications that could involve long incubation times at very high temperatures, disulfide bonds were shown to compromise nanobody refolding ability due to heat-induced disulfide shuffling and modifications of cysteine residues 21, 65 . This phenomenon can compromise the effect of disulfide bonds on thermodynamic stability and aggregation behavior. Second, applications that involve nanobody expression in the reducing environment of the cytosol strongly challenge nanobody stability, if a second disulfide bond is required. In vivo, nanobody folding proceeds from the reduced unfolded SCientiFiC REPORTS | (2018) 8:7934 | DOI:10.1038/s41598-018-26338-z state. Nanobodies with two disulfide bonds should therefore be avoided in applications that include cytosolic expression or should be improved by other strategies, such as adding solubilizing tags 23, 25 .
Methods
Expression and purification of nanobody binders. Dromedary-derived nanobody binders (n = 50) originated from different phage display screenings against various protein targets and were present in the pMECS vector coding for a C-terminal HA-and His6-tag. Llama-derived nanobodies (n = 18) were selected from a subtractive phage-display library against tissue lysates 66 and were present in the pHEN2 plasmid coding for a C-terminal Myc-and His6-tag. Nanobodies were expressed and purified as previously described in detail 23 .
Protein quantification. Nanobody concentration was determined spectrophotometrically at 280 nm in at least quadruplicate measurements for the initial data set shown in Figures 2 and 5 , otherwise in triplicates, using sequence-based extinction coefficients 67 and a Nanodrop ND-1000 instrument (Peqlab Biotechnologie, Erlangen, Germany).
Differential scanning fluorimetry and turbidity assay. Differential scanning fluorimetry (DSF) measurements were performed on a Prometheus NT.48 instrument (NanoTemper Technologies, Munich, Germany) with additional back-reflection optics for determining turbidity according to the manufacturer's instructions. To ensure equal buffer conditions, a buffer exchange was performed with all binders against a single batch of PBS, pH 7.4 using Zeba Spin desalting columns (Thermo Fischer, Waltham, USA) with a 7 kDa cut-off. Samples were centrifuged at 20,000 g for 10 mins prior their measurement and a heating rate of 0.5 °C/min was employed.
Fluorescence was monitored at wavelengths of 330 nm and 350 nm using an excitation wavelength of 280 nm. Nanobody performance in a reducing environment was tested at a protein concentration of 13.1 µM by adding TCEP to a final concentration of 25 mM immediately prior to the measurement using a stock solution of 250 mM TCEP, 100 mM Tris/NaOH, pH 7.5.
Data analysis from DSF measurements. The parameters T m , T on and T s were obtained from the
Prometheus NT.48 instrument software PR.ThermControl. All fitted values were visually checked in individual fluorescence and turbidity traces to remove possible artifacts. Statistical analysis including unpaired t-tests, Pearson correlation coefficients and linear regression models were calculated using standard functions in R.
To qualitatively characterize nanobody aggregation, turbidity signals were integrated over a range of 7 °C, starting from the aggregation onset temperature T s . In a customized R script, the mean turbidity signal of a 2 °C range below the aggregation onset temperature T s was used for baseline correction. If T s occurred during the cooling phase, the turbidity integral was determined in reverse orientation, using the mean turbidity signal of a 2 °C range above T s for baseline correction. The standard error SD Int of an integral was calculated by = ⋅ SD S D N Int 2 with SD being the standard error of the 2 °C range and N the number of integrated data points. This procedure was performed if a scattering onset temperature T s was detectable; otherwise integrals were set to zero.
To judge nanobody reversibility, fluorescence ratio differences were calculated using a customized R script. It determined the mean fluorescence ratio for the initial and final 2 °C of a temperature cycle and calculated the absolute value of their difference together with the standard error: = + SD S D SD Diff heat cool 2 2 with SD heat and SD cool as the standard errors of the 2 °C ranges of the heating and the cooling phase, respectively. The threshold of significance, which indicated non-reversibility of the folding reaction, was chosen to be three times the mean value of all observed standard errors SD Diff . Circular dichroism measurements. Nanobody melting curves were measured between 37 °C to 95 °C at a wavelength of 203 nm in a Jasco J715 CD spectrometer equipped with a Peltier temperature control unit using a heating rate of 0.5 °C/min and a protein concentration of 15 µM in PBS, pH 7.4. Curves were fitted according to Santoro and Bolen 68 , using the values at 37 °C and 95 °C of the fits to determine respective amplitudes and calculate the signal recovery after a full temperature cycle.
Aggregation kinetics. Nanobody monomer loss was measured in centrifugation assays at a protein concentration of 32.7 µM in PBS, pH 7.4. Nanobody aliquots were incubated at their respective T m value in a PCR cycler with a heated lid. At various time points, a single aliquot was centrifuged at 22,000 g for one minute at 4 °C and the protein concentration of the soluble fraction was measured spectrophotometrically in triplicates as described above using a Nanodrop ND-1000 instrument. Assuming the loss of soluble protein to be the aggregate fraction FA, the data was fitted to a single exponential function:
where A represents the final amplitude, k app the apparent aggregation rate constant and t the time. For testing the reversibility of aggregation, each aliquot was split in two aliquots after heat treatment. One was immediately assayed, the second after 24 h at room temperature.
Transmission electron microscopy. To discriminate nanobody aggregation states, protein samples were incubated for different time intervals at room temperature, T m , or 90 °C at a concentration of 32.7 µM in PBS, pH 7.4 and subsequently stored on ice. After loading the samples on a 300-mesh, carbon-coated grid, they were washed with PBS buffer, stained with 2% (w/v) uranyl acetate and imaged using a ZEISS EM 912 microscope with a Proscan CCD camera. Analytical Ultracentrifugation. Sedimentation were collected at a wavelength of 280 nm in the continuous scan mode using a spacing of 0.003 cm. Sedimentation velocity profiles were analyzed with the software DCDT+ 69 and obtained sedimentation coefficients were corrected to standard conditions (20 °C, in water). The protein partial specific volumes were calculated from the amino acid composition to 0.714 ml/g, solvent density and viscosity was calculated through summation of the contribution of buffer components to 1.005 g/cm 3 and 1.017 mPa*s at 20 °C using the program SEDNTERP.
